Israel Cancer Research Fund Inc.

Fiscal year ending 2024. Filed on November 6, 2025.

52 Vanderbilt Avenue 1410
New York, New York 10017

Israel Cancer Research Fund Inc. (EIN: 51-0181215) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Israel Cancer Research Fund Inc., a 501(c)(3) charitable organization, reported compensation for 5 out of 13 total employees. Among the employees shown here, the average compensation is $191,417. The highest compensated employee at Israel Cancer Research Fund Inc. is Alan Herman with fiscal year 2024 compensation of $325,977.

Revenue, expenses, and employee compensation

Revenue

$9,064,574

Expenses

$6,298,074

Employee compensation

$1,864,230

Reported Compensated Employees

Alan Herman

Executive Director

$325,977

$246,274 No related comp$79,703

Allyson Greenfield

Chicago Executive Director

$193,970

$155,587 No related comp$38,383

Tania Orenstein

Controller

$189,425

$176,015 No related comp$13,410

David Kweskin

Connecticut Director

$126,664

$117,987 No related comp$8,677

Beryl Chernov

Former National Executive Dir.(1/24)

$121,049

$98,640 No related comp$22,409

Non-Employee Board Members

Arnold M Baskies, M.D.

Executive Committee Member

Charles Ben Dayan

Executive Committee Member

David Malkin, M.D.

Mission Statement

TO SUPPORT CANCER RESEARCH IN ISRAEL, FOR THE BENEFIT OF ISRAEL AND ALL MANKIND.

Revisions to this organization profile

November 6, 2025:

2024 Israel Cancer Research Fund Inc. 990 filed

November 11, 2024:

2023 Israel Cancer Research Fund Inc. 990 filed

September 28, 2023:

2022 Israel Cancer Research Fund Inc. 990 filed

Get an email when new compensation information is released for Israel Cancer Research Fund Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

Powered by Talroo

Report a discrepancy →